We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Xeljanz
Australian Public Assessment Report
Device/Product Name
Xeljanz
Active ingredients
Tofacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04843-1-3
Submission Type
Extension of indications
Decision
Approved